25 July, 2022 Uncategorized

Meet Pantherna Therapeutics at BIO-Europe 2022

11 January, 2022 Uncategorized

Pantherna Therapeutics secures EUR 4.0 Mio. follow-on financing to advance its therapeutic mRNA development programs 

15 November, 2021 Allgemein

Astellas and Pantherna Enter into Technology Evaluation Agreement for Research of mRNA-based Regenerative Medicine.

28 May, 2021 Allgemein

Pantherna Therapeutics to be granted 2.2 millions EFRE public funding.

12 June, 2020 Allgemein

Pantherna Therapeutics GmbH signs an agreement for technology evaluation with Astellas Innovation Management LLC to evaluate Pantherna’s lipid nanoparticle transport system and mRNA molecules.

02 April, 2020 Allgemein

Successful follow-up financing for Pantherna Therapeutics’ development programs to fight Acute Respiratory Distress Syndrome

26 March, 2020 Allgemein

Pantherna Therapeutics GmbH and PROVIREX Genome Editing Therapies GmbH are developing lipid-based delivery systems for mRNA-directed genome editing of lymphocytes for the treatment of HIV and other life-threatening persistent viral diseases

20 February, 2020 Allgemein

Pantherna Therapeutics presented at the RNA Therapeutics Conference in London, UK

08 November, 2019 Allgemein

Pantherna Therapeutics to present at BIO-Europe 2019

01 November, 2019 Allgemein

Pantherna Therapeutics to present at mRNA Health Conference 2019